Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment - Pfizer (NYSE:PFE)
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several top-sellers.